Glaxosmithkline Pharmaceuticals to focus on 20 brands, 5 therapeutic segments: Report

16 Jul 2019 Evaluate

GlaxoSmithKline Pharmaceuticals, the Indian unit of British drug major GSK, is reportedly planning to  focus its energies on 20 brands and 5 therapeutic segments anti-infectives, dermatology, respiratory, gastro-intestinal and anti-pyretic to drive future growth in India.

The drug maker is also looking for deeper engagement with distribution channel partners and securing control over the supply chain with its own factories.

GlaxoSmithKline Pharmaceuticals (GSK Rx India) is one of the oldest pharmaceuticals company. The GSK India product portfolio includes prescription medicines and vaccines.

Glaxosmithkline Phar Share Price

2311.50 -68.35 (-2.87%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×